Topiramate · TOPIRAMATE 50 mg/1 · Tablet · Oral · Cipla USA Inc.
NDC 69097-0123-03 · 60 TABLET in 1 BOTTLE · ANDA · View full market →
15 companies supply this market — deep enough that no single failure threatens the supply. The price is down 11% over the past year, to $0.0350 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cipla USA Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cipla USA Inc. | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| C | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | TOPIRAMATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | TOPIRAMATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Topiramate — NDC 69097-0123-03," retrieved September 3, 2026, https://drugdashboards.com/drug/69097012303.
Free to cite with attribution — see how the data is put together.